Details of the Drug

General Information of Drug (ID: DMSPOAT)

Drug Name

2-(4-Phenoxy-phenyl)-1H-benzoimidazol-5-ylamine

Synonyms

CHEMBL179383; 2-(4-Phenoxy-phenyl)-1H-benzoimidazol-5-ylamine

Indication

Disease Entry	ICD 11	Status	REF
Discovery agent	N.A.	Investigative	[1]
------------------------------------------------------------------------------------

Drug Type

Small molecular drug

Structure

3D MOL

2D MOL

#Ro5 Violations (Lipinski): 0

Molecular Weight (mw)

301.3

Logarithm of the Partition Coefficient (xlogp)

4.1

Rotatable Bond Count (rotbonds)

3

Hydrogen Bond Donor Count (hbonddonor)

2

Hydrogen Bond Acceptor Count (hbondacc)

3

Chemical Identifiers

Formula: C19H15N3O
IUPAC Name: 2-(4-phenoxyphenyl)-3H-benzimidazol-5-amine
Canonical SMILES: C1=CC=C(C=C1)OC2=CC=C(C=C2)C3=NC4=C(N3)C=C(C=C4)N
InChI: InChI=1S/C19H15N3O/c20-14-8-11-17-18(12-14)22-19(21-17)13-6-9-16(10-7-13)23-15-4-2-1-3-5-15/h1-12H,20H2,(H,21,22)
InChIKey: YDXHPXOLZYGIGV-UHFFFAOYSA-N

Cross-matching ID

Molecular Interaction Atlas of This Drug

Drug Therapeutic Target (DTT)

DTT Name	DTT ID	UniProt ID	MOA	REF
Serine/threonine-protein kinase Chk2 (RAD53)	TT9ABMF	CHK2_HUMAN	Inhibitor	[1]

------------------------------------------------------------------------------------

Molecular Interaction Atlas (MIA)

Jump to Detail Molecular Interaction Atlas of This Drug

References

1	Checkpoint kinase inhibitors: SAR and radioprotective properties of a series of 2-arylbenzimidazoles. J Med Chem. 2005 Mar 24;48(6):1873-85.